These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7202830)

  • 1. Ticarcillin therapy of risk patients with infections due to Pseudomonas aeruginosa.
    Welter J; Wittman DH; Freitag V
    J Int Med Res; 1981; 9(1):44-51. PubMed ID: 7202830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin.
    Parry MF; Neu HC; Merlino M; Gaerlan PF; Ores CN; Denning CR
    J Pediatr; 1977 Jan; 90(1):144-8. PubMed ID: 401521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
    Bauernfeind A; Petermüller C; Dietzel M
    Infection; 1979; 7(1):21-6. PubMed ID: 422252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefsulodin for the treatment of Pseudomonas infections--a study comparing cefsulodin and ticarcillin.
    van der Meer JW; Matze-van der Lans A; Mattie H
    Neth J Med; 1989 Jun; 34(5-6):233-42. PubMed ID: 2671757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in resistance of Pseudomonas aeruginosa to beta-lactams in a general intensive care unit over a three-year period. Role of piperacillin].
    Bercault N; Martin P; Demasure M; Poisson D; Gueveler C
    Pathol Biol (Paris); 1991 Feb; 39(2):105-9. PubMed ID: 1901983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE; Johnson CE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):406-8. PubMed ID: 6814354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timentin in the treatment of nosocomial bronchopulmonary infections in intensive care units.
    Schwigon CD; Hulla FW; Schulze B; Maslak A
    J Antimicrob Chemother; 1986 May; 17 Suppl C():115-22. PubMed ID: 3636326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Community-acquired Pseudomonas aeruginosa bacteremic pneumonia in a "healthy" subject].
    Illinger J; Mohammedi I; Martin O; Argaud L; St Denis M; Robert D
    Presse Med; 2003 Jul; 32(24):1123. PubMed ID: 12947742
    [No Abstract]   [Full Text] [Related]  

  • 10. Ticarcillin.
    Med Lett Drugs Ther; 1977 Feb; 19(4):17-8. PubMed ID: 402545
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative efficacies of piperacillin, azlocillin, ticarcillin, aztreonam, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Schiff JB; Pennington JE
    Antimicrob Agents Chemother; 1984 Jan; 25(1):49-52. PubMed ID: 6538397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.
    Cone LA; Woodard DR; Stoltzman DS; Byrd RG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):33-6. PubMed ID: 3899005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa keratitis treated with ticarcillin and tobramycin.
    Prociv P
    Med J Aust; 1979 Jul; 2(2):63-4. PubMed ID: 114740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticarcillin in the treatment of Pseudomonas aeruginosa infections.
    Prociv P; Pearman J
    Med J Aust; 1979 Jul; 2(1):38. PubMed ID: 502947
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ticarcillin sodium in the field of orodental surgery].
    Tsuji T; Hasui Y; Hiromi A; Kawashima J; Ueno Y
    Shikai Tenbo; 1985 Jul; 66(1):225-30. PubMed ID: 3865425
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia.
    Rapp RP; Young B; Foster TS; Tibbs PA; O'Neal W
    Pharmacotherapy; 1984; 4(4):211-5. PubMed ID: 6384945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.
    Schaad UB; Desgrandchamps D; Kraemer R
    Acta Paediatr Scand; 1986 Jan; 75(1):128-38. PubMed ID: 3082103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.